Investment Summary

Siparex Invests In Pharmactive Biotech Products

On June 28, 2021, private equity firm Siparex invested in life science company Pharmactive Biotech Products

Investment Highlights
  • This is Siparex’s 3rd transaction in the Life Science sector.
  • This is Siparex’s 1st transaction in Spain.

Investment Summary

Date 2021-06-28
Target Pharmactive Biotech Products
Sector Life Science
Investor(s) Siparex
Deal Type Stake Purchase

Target

Pharmactive Biotech Products

Madrid, Spain
Pharmactive Biotech Products specializes in the research, development, and extraction of natural ingredients used in the dietary supplement industry. The Company produces plant-based compounds, including extracts from saffron and black garlic, and manages activities across the full value chain from cultivation and extraction to validation and laboratory testing. Pharmactive Biotech Products was founded in 2009 and is based in Madrid, Spain.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Siparex

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1977
PE ASSETS 4.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Siparex is a French private equity firm that looks to invest mezzanine or equity capital in companies at all stages of development. The Firm separates its investment activity into mid-market, mezzanine, and small-cap. Within mid-market, Siparex looks to invest €2.5 to €40 million in companies with at least €15 million in sales. Prospective transaction situations include buyouts, shareholder liquidity events, and growth capital financings. The Firm will consider all business sectors. Within its mezzanine group, Siparex looks to invest €2 to €10 million to support growth, acquisitions, refinancings, and restructurings. The small-cap group seeks investments starting at €300K in early-stage companies as well as those undergoing expansion or being sold. Siparex was formed in 1977 and is based in Paris.


DEAL STATS #
Overall 61 of 102
Sector: Life Science M&A 3 of 4
Type: Stake Purchase M&A Deals 9 of 18
Country: Spain M&A 1 of 1
Year: 2021 M&A 3 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-22 Winncare Group

Rueil-Malmaison, France

Winncare Group is a provider of medical products for dependent people and the elderly in France and other European countries. Winncare Group is based in Rueil-Malmaison, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-23 Speechi

Lille, France

Speechi develops and supplies interactive hardware and software solutions such as interactive whiteboards/screens, document cameras, and collaboration-platform software for education and corporate use. Speechi was founded in 2004 and is based in Lille, France.

Buy -